The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer
Completed · Phase 1
Conditions studied: Carcinoma, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms
In brief
This study is to examine the effects on tumors of AZD2171, in the treatment of NSCLC or HNC. The safety and tolerability of AZD2171 will also be studied.
Key facts
- Study ID
- NCT00243347
- Run by
- AstraZeneca
- People needed
- 19
- Starts
- 2005-12-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2013-10-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically or cytologically confirmed head and neck cancer (HNC) or unresectable stage IIIb or IV non-small cell lung cancer (NSCLC)
- At least one lesion able to be used for tumor biopsy and to be measured by FDG-PET Scan
- Considered suitable for treatment of NSCLC with no prior biological or immunological therapy for disease
- Or considered suitable for treatment for metastatic or recurrent HNC with no prior biological or immunological therapy for disease
You may not qualify if…
- NSCLC: Have received more than 2 previous chemotherapy regimens or have received the last chemotherapy or radiotherapy within 28 days of first dose of AZD2171
- HNC: Previous chemotherapy or radiotherapy if received 28 days of first dose of AZD2171
- Untreatable, unstable brain or meningeal metastases.
- Abnormal liver and kidney blood chemistries
- History of poorly controlled hypertension with resting blood pressure of >150/100
- Recent (< 14 days) major surgery or a surgical incision not fully healed
- Diabetes patients with type I insulin dependent diabetes or poorly controlled type II
- Significant hemorrhage or hemoptysis
- Presence of necrotic/hemorrhagic tumor or metastases
Where it is running
- Research Site — Houston, Texas, United States
- Research Site — Barcelona, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.